Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Youssef, Mohamed A F M ^a   Van Veen, Fulco Der ^a   Al Inany, Hesham G ^b   Griesinger, Georg ^c   Mochtar, Monique H ^a   Van Wely, Madelon ^d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b CAIRO UNIVERSITY   (Egypt)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN;

CLINICAL PROTOCOL; CLINICAL RESEARCH; DATA ANALYSIS; HUMAN; METHODOLOGY; OOCYTE MATURATION; OUTCOME ASSESSMENT; OVULATION INDUCTION; REVIEW;

EID: 77950144916     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008046     Document Type: Review

References (23)

1. Delvigne 2003 Delvigne A, Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome. Human Reproduction Update 2003;9:77-96.
2. Elchalal 1997 Elchalal U, Schenker J. The pathophysiology of ovarian hyperstimulation syndrome: views and ideas. Human Reproduction 1997;12(6):1129-37.
3. Engmann 2009 Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after co-treatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertility and Sterility 2009;89(1):84-91.
4. Fauser 2002 Fauser BC, De Jong D, Olivennes F, Warmsby H, Tay CJ, Itskovitz-Eldor J, et al.Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after co treatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. Journal of Clinical Endocrinology and Metabolism 2002;8(2):709-15.
5. Felberbaum 1995 Felberbaum PE, Reissmannb T, Kiipkera W, Bauera O, Al Hasania S, Diedrich C, Diedricha K. Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (cetrorelix) in women with tubal infertility. European Journal of Obstetrics, Gynecology, and Reproductive Biology 1995;61:151-5.
6. Forman 1998 Forman R, Fries N, Tastart J, Belaisch J, Hazout A, Frydman R. Evidence of an adverse effect of elevated serum estradiol concentrations on embryo implantation. Fertility and Sterility 1998;49:118-22.
7. Higgins 2008 Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 www.cochranehandbook.org. 2008.
8. Hopewell 2007 Hopewell S, Clarke MJ, Lefebvre C, Scherer RW. Handsearching versus electronic searching to identify reports of randomised trials. Cochrane Database of Systematic Reviews 2007, (Issue 2).
9. Hopewell 2007a Hopewell S, McDonald S, Clarke MJ, Egger M. Grey literature in meta-analyses of randomized trials of health care interventions. Cochrane Database of Systematic Reviews 2007, (Issue 2).
10. Hopewell 2007b Hopewell S, Clarke MJ, Stewart L, Tierney J. Time to publication for results of clinical trials. Cochrane Database of Systematic Reviews 2007, (Issue 2).
11. Humaidan 2005 Humaidan P, Bredkjær HE, Bungum L, Bungum M, Grøndahl ML, Westergaard L, et al.GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Human Reproduction 2005;20(5):1213-20.
12. Itskovitz-Eldor 2000 Itskovitz-Eldor J, Kol S, Mannaerts B. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: Preliminary report. Human Reproduction 2000;15(9):1965-8.
13. Kol 2004 Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertility and Sterility 2004;81:1-5.
14. Lweit 1996 Lewit N, Kol S, Manor D, Itskovitz-Eldor J. Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome. Human Reproduction 1996;7(11):1399-402.
15. Nevo 2003 Nevo O, Eldar-Geva T, Kol S, Itskovitz-Eldor J. Lower levels of inhibin A and pro-C during the luteal phase after triggering oocyte maturation with a gonadotropin releasing hormone agonist versus human chorionic gonadotropin. Fertility and Sterility 2003;79(51):1123-8.
16. Olivennes 2001 Olivennes F, Fanchin R, Bouchard P, Taieb J, Frydman R. Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with GnRH antagonist. Fertility and Sterility 1996;66:151-3.
17. Orvieto 2006 Orvirto R, Zagatsky I, Yulzari-roll V, La Marca A, Fisch B. Substituiting human chorionic gonadotropin by gonadotropin-releasing hormone agonist to trigger final follicular maturation, during controlled ovarian hyperstimulation, results in less systemic inflammation. Gynecological Endocrinology 2006;22(8):437-40.
18. Pirard 2006 Pirard C, Donnez J, Loumaye E. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study. Human Reproduction 2006;21:1894-900.
19. Segal 1992 Segal S, Casper RF. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in invitro fertilization. Fertility and Sterility 1992;57:1254-8.
20. Simon 1998 Simon C, Garcia Velasco JJ, Valbuena D, Peinado JA, Moreno C, Rehmohi J, Pellicer A. Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone stepdown regimen. Fertility and Sterility 1998;70:234-9.
21. Song 2002 Song F, Khan KS, Dinnes J, Sutton AJ. Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. International Journal of Epidemiology 2002;31(1):88-95.
22. Stuck 1998 Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ 1998;316(7129): 469-70.
23. Valbauena 2001 Valbuena D, Martin J, de Palbo JL, Remohi J, Pellicer A, Simon C. Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo. Fertility and Sterility 2001;76:962-8.